Bortezomib/Cyclophosphamide/Dexamethasone-Daratumumab/Hyaluronidase Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen containing bortezomib, cyclophosphamide, dexamethasone and daratumumab and hyaluronidase that may be used in the treatment of systemic light chain amyloidosis. A dose-modified version may be used for the treatment of systemic light chain amyloidosis.

**Synonyms:** - Bortezomib-Cyclophosphamide-Daratumumab and Hyaluronidase -Dexamethasone Regimen - Bortezomib-Cyclophosphamide-Daratumumab and Hyaluronidase-Dexamethasone - Bortezomib-Cyclophosphamide-Darzalex Faspro-Dexamethasone - Bortezomib-Cyclophosphamide-Dexamethasone Plus Daratumumab and Hyaluronidase - Bortezomib-Cyclophosphamide-Dexamethasone Plus Daratumumab and Hyaluronidase-fihj - Bortezomib/Cyclophosphamide/Daratumumab and Hyaluronidase /Dexamethasone - Bortezomib/Cyclophosphamide/Daratumumab and Hyaluronidase /Dexamethasone Regimen - Bortezomib/Cyclophosphamide/Daratumumab and Hyaluronidase-fihj/Dexamethasone Regimen - Bortezomib/Cyclophosphamide/Dexamethasone Plus Daratumumab and Hyaluronidase - Bortezomib/Cyclophosphamide/Dexamethasone Plus Daratumumab and Hyaluronidase Regimen - Bortezomib/Cyclophosphamide/Dexamethasone Plus Daratumumab and Hyaluronidase-fihj - Bortezomib/Cyclophosphamide/Dexamethasone Plus Daratumumab/Hyaluronidase Regimen - Bortezomib/Cyclophosphamide/Dexamethasone Plus Darzalex Faspro - CyBorD-Daratumumab and Hyaluronidase-fihj - Dara-CyBorD - Daratumumab and Hyaluronidase-fihj -CyBorD - Daratumumab and Hyaluronidase-fihj Plus VCd - Daratumumab and Hyaluronidase-fihj/VCd - Darzalex Faspro/VCd - VCD-Daratumumab and Hyaluronidase-fihj - Velcade-Cyclophosphamide-Dexamethasone Plus Darzalex Faspro Regimen